🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: AZD6234

Found 14 matching trials

Assess the Safety, Tolerability, and Pharmacokinetics of AZD6234 Following Single Ascending Dose Administration to Healthy Subjects Who Are Overweight or Obese

PHASE1

A study in healthy male and female participants of non-childbearing potenti...

Status

Completed

Location

Research Site

Start Date

2022-09-20

Trial ID

NCT05511025

Treatments Being Tested

AZD6234 Placebo Acetaminophen

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese

PHASE1

A study in healthy male and female participants of non-childbearing and chi...

Status

Completed

Location

Research Site

Start Date

2023-11-13

Trial ID

NCT06132841

Treatments Being Tested

AZD6234 Placebo

Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD6234

PHASE1

This study will evaluate the pharmacokinetics (PK), safety, and tolerabilit...

Status

Completed

Location

Research Site

Start Date

2025-02-24

Trial ID

NCT06845813

Treatments Being Tested

AZD6234

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

PHASE2

This Phase II study is a randomized, parallel group, double blinded, placeb...

Status

Active Not Recruiting

Location

Research Site

Start Date

2025-03-12

Trial ID

NCT06851858

Treatments Being Tested

AZD6234 Placebo to match

A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

PHASE2

The purpose of this study is to determine whether treatment with AZD9550 wh...

Status

Completed

Location

Research Site

Start Date

2025-02-18

Trial ID

NCT06862791

Treatments Being Tested

AZD9550 AZD6234 Placebo comparator

A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234

PHASE1

The purpose of this study is to examine the safety and tolerability of AZD6...

Status

Recruiting

Location

Research Site

Start Date

2026-03-20

Trial ID

NCT07546760

Treatments Being Tested

AZD6234 AZD9550

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

PHASE3

The study will evaluate how well AZD6234 works and how safe it is in adults...

Status

Recruiting

Location

Research Site

Start Date

2026-08-19

Trial ID

NCT07784725

Treatments Being Tested

AZD6234 Placebo

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

PHASE3

The study will evaluate how well AZD6234 works and how safe it is in adults...

Status

Not Yet Recruiting

Location

Research Site

Start Date

2026-08-21

Trial ID

NCT07776509

Treatments Being Tested

AZD6234 Placebo

This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight

PHASE2

This study is to assess the safety and tolerability, PK characterisation, e...

Status

Active Not Recruiting

Location

Research Site

Start Date

2025-05-20

Trial ID

NCT07017179

Treatments Being Tested

AZD6234 Placebo AZD9550 Plocebo AZD6234 in combination with AZD9550 Placebo

A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity

PHASE1

This study will measure the effects of multiple doses of AZD6234, AZD9550 a...

Status

Recruiting

Location

Research Site

Start Date

2025-06-04

Trial ID

NCT07013643

Treatments Being Tested

AZD6234 Ethinyl estradiol/Levonorgestrel (EE/LEVO)Acetaminophen (APAP)AZD9550

Previous Next